Navigation Links
STAAR Surgical Announces Second Quarter 2014 Results Release Date, Conference Call And Webcast
Date:7/16/2014

MONROVIA, Calif., July 16, 2014 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today announced that it will release its financial results for the second quarter ended July 4, 2014 on Wednesday, July 30, 2014 after the market close. STAAR will host a conference call and video webcast on Wednesday, July 30 at 5:00 p.m. Eastern / 2:00 p.m. Pacific to discuss these results and recent corporate developments. The dial-in number for the conference call is 866-515-2907 for domestic participants and 617-399-5121 for international participants, both using the passcode 24164533.  The Company will also be using slides to illustrate its second quarter results and operational progress. The slides and live video webcast with accompanying slides can be accessed from the investor relations section of the STAAR website at www.staar.com.A taped replay of the conference call will also be available beginning approximately one hour after the call's conclusion for seven days.  This replay can be accessed by dialing 888-286-8010 for domestic callers and 617-801-6888 for international callers, both using passcode 54025734.  An archived video webcast will also be available at www.staar.com.

About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye and delivery systems there for. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or "ICL." A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL." More than 450,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: www.visianinfo.com. STAAR has approximately 335 full time employees and markets lenses in over 60 countries. Headquartered in Monrovia, CA, it manufactures in Aliso Viejo, CA and Monrovia, CA. For more information, please visit the Company's website at www.staar.com.  CONTACT:Investors MediaEVC Group EVC GroupDoug Sherk, 415-652-9100 Nicole Kruse, 212-850-6025


'/>"/>
SOURCE STAAR Surgical Company
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. STAAR Surgical Celebrates Over 300,000 Successful Visian® ICL Implants at ASCRS Congress
2. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
3. B. Riley Revises Timing of STAAR Surgical Presentation at Investor Conference
4. STAAR Surgical To Present At The Benchmark And Jefferies Investor Conferences
5. STAAR Surgical Provides Outlook On Second Quarter 2012 Financial Results
6. STAAR Surgical Reports Second Quarter 2012 Financial Results
7. STAAR Surgical To Present At The 32nd Annual Canaccord Growth Conference
8. STAAR Surgical Expands Footprint for Growth with Lease on Adjacent Building in Monrovia, California
9. STAAR Surgical Builds Leadership Team to Drive Growth Opportunities
10. STAAR Surgical Appoints Charles Slacik To Its Board Of Directors
11. STAAR Surgical Reports Third Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... -- Sanovas, Inc., a life science asset holding ... its wholly owned subsidiary, Intubation Science, Inc., and its LightSpeed ... - http://photos.prnewswire.com/prnh/20161202/445251LOGO   ... Sanovas, Inc. ... There are over 40 million Endotracheal Intubations performed ...
(Date:12/5/2016)... 2016  CVS Health, the nation,s largest pharmacy innovation ... score of 100 percent on the Corporate Equality Index ... an annual national benchmarking survey and report on corporate ... the Human Rights Campaign Foundation. "Our ... colleagues, customers and suppliers bring to CVS Health," said ...
(Date:12/5/2016)... PARSIPPANY, N.J. , Dec. 5, 2016 /PRNewswire/ ... announced preliminary safety and efficacy data from a ... selective MDM2 inhibitor, suggesting that DS-3032 may be ... acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome ... of the phase 1 study of DS-3032 were presented ...
Breaking Medicine Technology:
(Date:12/5/2016)... ... December 05, 2016 , ... The Avamere Family ... – Avamere Transitional Care of Puget Sound ; located at 630 S ... center will provide patients recovering from illness or injury with intensive skilled nursing ...
(Date:12/5/2016)... (PRWEB) , ... December 05, 2016 , ... Researchers at ... on the growing brains of young athletes. Over the course of three years, researchers ... through unique mouth guards. The mouth guards, equipped with special sensors, will track the ...
(Date:12/5/2016)... Fla (PRWEB) , ... December 05, 2016 , ... ... as Keynote speaker for the 21st Annual International Congress on Hematologic Malignancies®: Focus ... announcement, PER® president, Phil Talamo said, “We are honored to have Amy E. ...
(Date:12/5/2016)... ... December 05, 2016 , ... Dr. Barry M. Weintraub, one of New York ... participated in the 36th Annual Cutting Edge Aesthetic Symposium at the Waldorf Astoria in ... that perfect, yet natural-looking, nose. Dr. Weintraub, who is world-renowned for his expertise in ...
(Date:12/5/2016)... and MALVERN, PA (PRWEB) , ... ... ... Supplies Management ("CSM"), a Great Point Partners ("GPP") portfolio company, today announced ... – Clinical Supplies ("TCS"). TCS was previously a subsidiary of Chiltern ...
Breaking Medicine News(10 mins):